What is esophageal cancer?
Esophageal cancer begins when cells lining the esophagus — the muscular tube that carries food and liquid from the throat down to the stomach — start to grow out of control. It can develop anywhere along the esophagus, starting in the innermost layer of the wall and, over time, growing outward into deeper layers and potentially into nearby structures or lymph nodes.
What are the main types of esophageal cancer?
There are two main types, and they behave differently enough that they’re often thought of almost as separate diseases:
Adenocarcinoma: Starts in the gland cells that produce mucus, typically in the lower third of the esophagus, near the stomach. It’s the more common type in the United States and other Western countries, and it’s closely linked to chronic acid reflux and Barrett’s esophagus.
Squamous cell carcinoma: Starts in the flat cells that line the esophagus, and can occur anywhere along its length, though it’s more often found in the upper and middle portions. It’s the more common type worldwide, particularly in parts of Asia and East Africa, and is most strongly linked to tobacco and alcohol use.
What are the symptoms of esophageal cancer?
Esophageal cancer often causes few or no symptoms in its earliest stages, which is one reason it tends to be found later than some other cancers. As a tumor grows, it can begin to narrow the esophagus and cause noticeable changes, including:
- Difficulty or pain swallowing (dysphagia), often starting with solid food and, as it progresses, extending to soft foods and eventually liquids
- Unintended weight loss
- Chest pain, pressure, or burning, often behind the breastbone
- Persistent cough, hoarseness, or a feeling of choking
- Worsening indigestion or heartburn
- Vomiting, or vomiting or coughing up blood
None of these symptoms means a person definitely has esophageal cancer — they’re far more often caused by other, more common conditions. But persistent difficulty swallowing in particular is a symptom that should always be evaluated by a doctor rather than managed on your own.
What is Barrett’s esophagus, and how does it relate to esophageal cancer?
Barrett’s esophagus is a condition in which long-term acid reflux (gastroesophageal reflux disease, or GERD) damages the lining of the lower esophagus, causing the normal cells there to be gradually replaced by a different type of cell more similar to those found in the stomach or intestine. It develops in some people who have had reflux for a long time, though many people with Barrett’s esophagus have few or no symptoms beyond the heartburn that led to the diagnosis. Barrett’s esophagus raises the risk of developing esophageal adenocarcinoma, which is why people diagnosed with it are often followed with periodic endoscopic surveillance. It’s worth emphasizing, though, that most people with Barrett’s esophagus never go on to develop esophageal cancer.
What causes esophageal cancer, and what are the risk factors?
There’s no single cause, and risk factors differ somewhat depending on which type is involved. Established risk factors include:
- Tobacco use: Smoking is a major risk factor for both main types of esophageal cancer, and risk rises with how much and how long a person has smoked.
- Alcohol use: Heavier drinking raises risk, particularly for squamous cell carcinoma. Combining tobacco and alcohol raises risk considerably more than either one alone.
- Chronic acid reflux (GERD) and Barrett’s esophagus: Long-standing reflux is a key risk factor for adenocarcinoma, largely through its role in causing Barrett’s esophagus.
- Obesity: Excess body weight is linked to a higher risk of adenocarcinoma, partly because it’s associated with more frequent acid reflux.
- Diet and very hot beverages: A diet low in fruits and vegetables, and regularly drinking very hot liquids, have both been linked to higher risk, particularly for squamous cell carcinoma.
- Age and sex: Risk rises after age 55, and men are affected considerably more often than women.
- Other esophageal conditions: Achalasia (a disorder where the muscle at the bottom of the esophagus doesn’t relax properly) and Plummer-Vinson syndrome (which causes web-like tissue growths that narrow the esophagus) are both linked to increased risk.
Is esophageal cancer hereditary?
In most cases, no — the large majority of esophageal cancers are linked to lifestyle and environmental risk factors like those above, rather than an inherited gene change. A very small number of cases are tied to rare inherited conditions, the best documented of which is tylosis with esophageal cancer (also called Howel-Evans syndrome), caused by a change in the RHBDF2 gene. People with this condition typically have unusually thick skin on the palms of their hands and soles of their feet and face a substantially elevated lifetime risk of esophageal cancer.
Having a close relative with esophageal cancer, especially adenocarcinoma, does appear to modestly raise a person’s own risk in some studies, though this is much less pronounced than the hereditary patterns seen in some other cancers. Anyone with a strong family history or features suggestive of an inherited syndrome may want to discuss genetic counseling with their doctor.
How is esophageal cancer diagnosed?
Diagnosis typically starts with an upper endoscopy, in which a thin, flexible camera is passed down the throat to examine the esophagus directly and take a tissue sample (biopsy) of any suspicious area. A barium swallow study, in which X-rays are taken after a person drinks a contrast liquid, can also help show narrowing or irregularities in the esophagus. Once cancer is confirmed, additional imaging — such as endoscopic ultrasound, CT scans, or PET scans — is used to determine how deeply the tumor has grown and whether it has spread, which guides the treatment plan.
How is esophageal cancer staged?
Staging describes how far the cancer has grown and spread, and it’s central to planning treatment for esophageal cancer specifically, because it determines whether a curative or a palliative approach makes more sense. In broad terms, staging considers how deep the tumor has grown into the esophageal wall, whether it has reached nearby lymph nodes, and whether it has spread to distant organs. Because early esophageal cancer often causes no symptoms, accurate staging typically requires a combination of endoscopic ultrasound and cross-sectional imaging rather than any single test.
How is esophageal cancer treated?
Treatment depends heavily on the cancer’s type, location, and stage, and often combines more than one approach:
- Endoscopic treatment: For very early cancers confined to the innermost lining, procedures done through an endoscope (such as endoscopic mucosal resection) can sometimes remove the cancer without conventional surgery.
- Surgery: Removing part or all of the esophagus (esophagectomy), often reconstructing the digestive tract using part of the stomach or intestine.
- Chemotherapy and radiation therapy: Frequently used together (chemoradiation), either before surgery to shrink the tumor or as the main treatment when surgery isn’t an option.
- Targeted therapy and immunotherapy: Newer treatments aimed at specific features of the cancer, such as drugs targeting HER2-positive adenocarcinomas, or immune checkpoint inhibitors, which are increasingly used for certain esophageal cancers.
- Palliative care: For cancer that can’t be cured, treatments such as esophageal stents, radiation, or laser therapy can help relieve swallowing difficulty and improve quality of life.
Why is esophageal cancer often found at a later stage?
Because the esophagus is relatively flexible and roomy, a tumor often has to grow fairly large before it noticeably narrows the passage and causes symptoms like difficulty swallowing. Unlike some cancers, there’s no widely recommended screening test for esophageal cancer in the general population, so most cases are diagnosed only after symptoms appear. The main exception is people with known Barrett’s esophagus, who may be offered periodic endoscopic surveillance specifically to catch any early changes sooner.
What is the outlook for esophageal cancer?
Outlook depends heavily on the stage at diagnosis, which is why esophageal cancer’s overall statistics can look more sobering than the picture for an individual caught early. According to National Cancer Institute SEER data, the overall five-year relative survival rate across all stages combined is roughly 20 to 22 percent. But for cancer that’s still localized to the esophagus at diagnosis, the five-year relative survival rate rises to somewhere around 45 to 50 percent, and it’s markedly lower for cancer that has spread to nearby tissue or to distant organs.
That gap is largely a reflection of how often esophageal cancer is diagnosed after it has already spread, rather than a fixed feature of the disease itself. Survival statistics describe outcomes across large groups of people with similar diagnoses; they can’t predict what will happen for any one individual, which is worth discussing directly with your own oncologist.
Can esophageal cancer be prevented?
There’s no guaranteed way to prevent it, but several well-supported steps can meaningfully lower risk: not using tobacco in any form, limiting alcohol, maintaining a healthy body weight, and eating a diet rich in fruits and vegetables. For people with chronic, poorly controlled acid reflux, working with a doctor to manage GERD effectively may help reduce the risk of Barrett’s esophagus developing in the first place.
For those already diagnosed with Barrett’s esophagus, regular endoscopic surveillance as recommended by a gastroenterologist is the main tool for catching any precancerous changes early, when they’re far more treatable.
Does having heartburn or GERD mean I should be worried about esophageal cancer?
Occasional heartburn is extremely common and, on its own, is not a sign of cancer. What raises concern is frequent, longstanding reflux, especially heartburn occurring more than a couple of times a week over months or years, since that’s the pattern most associated with Barrett’s esophagus and, in turn, a higher risk of adenocarcinoma. If reflux is frequent, poorly controlled by over-the-counter antacids, or accompanied by difficulty swallowing, unintended weight loss, or vomiting blood, it’s worth having evaluated by a doctor, who can determine whether further testing, such as an endoscopy, makes sense.
A note on this information: This FAQ is provided for general education and does not replace advice from a qualified healthcare professional. If you or someone you love has questions about a specific diagnosis, symptom, or treatment option, please talk with a doctor. In the United States, the National Cancer Institute’s information specialists can be reached at 1-800-4-CANCER, and the American Cancer Society’s helpline is available 24/7 at 1-800-227-2345.
Sources consulted:
- National Cancer Institute (NCI), cancer.gov — Esophageal Cancer Treatment (PDQ®) and SEER Cancer Stat Facts: Esophageal Cancer
- American Cancer Society, cancer.org — Esophageal Cancer overview, risk factors, and causes/prevention pages
- World Health Organization — cancer fact sheets and global cancer statistics (GLOBOCAN)
- UT MD Anderson Cancer Center — “What is Esophageal Cancer?” overview
- American College of Gastroenterology — Esophageal Cancer patient information
